BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7383460)

  • 1. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity erythrocyte rosette formation and inhibition in premalignant disease of the uterine cervix.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3955-8. PubMed ID: 6861158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.
    Kurman RJ; Jenson AB; Lancaster WD
    Am J Surg Pathol; 1983 Jan; 7(1):39-52. PubMed ID: 6299124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix.
    Maier RC; Norris HJ
    Obstet Gynecol; 1980 Sep; 56(3):361-4. PubMed ID: 7422175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoperoxidase demonstration of papillomavirus antigen in dysplasia of the uterine cervix].
    Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M; Higashiiwai H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):411-5. PubMed ID: 2984298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical follow-up and the cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer.
    Saksela E; Meyer B
    Med Biol; 1976 Jun; 54(3):217-22. PubMed ID: 940364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical intraepithelial glandular neoplasia diagnosis and significance in relation to squamous precancerous lesions.
    Bhambhani S; Kaushik N; Khan IU; Luthram UK
    Indian J Cancer; 1990 Dec; 27(4):211-6. PubMed ID: 2090576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoantigen loss in cervical neoplasia. Demonstration by immunofluorescence and immunoperoxidase techniques.
    Bonfiglio TA; Feinberg MR
    Arch Pathol Lab Med; 1976 Jun; 100(6):307-14. PubMed ID: 57765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
    Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
    Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
    Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
    J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of gynecological malignancies.
    DiSaia PJ
    J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma.
    van de Linde AW; Streefkerk M; Schuurman HJ; te Velde ER; Kater L
    Br J Cancer; 1983 Jan; 47(1):147-53. PubMed ID: 6821628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunofluorescent study of basement membranes in squamous cell carcinoma of the cervix, vagina, and vulva.
    Pertschuk LP; Boyce JG; Urcuyo R
    Obstet Gynecol; 1977 Apr; 49(4):417-20. PubMed ID: 323765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmosomes and gap junctions in precarcinomatous and carcinomatous conditions of squamous epithelia. An electron microscopic and morphometrical study.
    Kocher O; Amaudruz M; Schindler AM; Gabbiani G
    J Submicrosc Cytol; 1981 Apr; 13(2):267-81. PubMed ID: 7338968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.